Oliver Luxxe Assets LLC increased its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 36.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 84,009 shares of the company’s stock after purchasing an additional 22,534 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in Avantor were worth $2,173,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Gateway Investment Advisers LLC raised its holdings in Avantor by 189.7% in the 3rd quarter. Gateway Investment Advisers LLC now owns 203,022 shares of the company’s stock worth $5,252,000 after purchasing an additional 132,953 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after purchasing an additional 3,700 shares during the period. UMB Bank n.a. bought a new position in Avantor in the 3rd quarter worth $49,000. Dynamic Advisor Solutions LLC raised its holdings in Avantor by 3.3% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 23,623 shares of the company’s stock worth $611,000 after purchasing an additional 749 shares during the period. Finally, GAMMA Investing LLC raised its holdings in Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after acquiring an additional 1,285 shares during the period. 95.08% of the stock is owned by institutional investors.
Avantor Trading Up 1.1 %
AVTR opened at $24.75 on Monday. The firm has a market cap of $16.81 billion, a P/E ratio of 63.46, a P/E/G ratio of 2.93 and a beta of 1.33. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The stock has a 50-day moving average of $25.66 and a 200 day moving average of $24.34.
Insider Buying and Selling at Avantor
In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.50% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Evercore ISI decreased their price target on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Barclays raised their price target on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Morgan Stanley raised their price objective on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Wells Fargo & Company assumed coverage on Avantor in a research report on Tuesday, August 27th. They set an “overweight” rating and a $30.00 price objective for the company. Finally, Royal Bank of Canada restated an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research report on Thursday, September 26th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Avantor presently has an average rating of “Moderate Buy” and a consensus target price of $28.00.
Get Our Latest Report on Avantor
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- How Technical Indicators Can Help You Find Oversold Stocks
- 3 Stocks Under $20 for Buy-and-Hold Investors Seeking Growth
- What Are Dividend Challengers?
- BlackRock’s Earnings Reveal Market Shift: Why Bonds Are in Favor
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- JPMorgan Can Hit New Highs This Year: Here’s Why
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.